Skip to main content
Account

Peer review reports

From: In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China

Original Submission
12 Sep 2018 Submitted Original manuscript
12 Oct 2018 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 2
12 Oct 2018 Submitted Manuscript version 2
7 Nov 2018 Reviewed Reviewer Report - Abbas Farahani
11 Feb 2019 Reviewed Reviewer Report - Reviewer 2
17 Mar 2019 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 3
17 Mar 2019 Submitted Manuscript version 3
21 Mar 2019 Reviewed Reviewer Report - Abbas Farahani
10 Apr 2019 Reviewed Reviewer Report - Reviewer 2
24 Apr 2019 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 4
24 Apr 2019 Submitted Manuscript version 4
4 May 2019 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 5
4 May 2019 Submitted Manuscript version 5
9 May 2019 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 6
9 May 2019 Submitted Manuscript version 6
14 May 2019 Author responded Author comments - Chunjiang Zhao
Resubmission - Version 7
14 May 2019 Submitted Manuscript version 7
Publishing
15 May 2019 Editorially accepted
10 Jun 2019 Article published 10.1186/s12879-019-4093-1

Learn about peer review

Back to article page

Navigation